Caixin
Apr 21, 2022 08:00 AM

Beihai Gofar Chuanshan Biological Co.,Ltd.’s Net Profit Rose 114.5% in First Quarter of 2022

Beihai Gofar Chuanshan Biological Co.,Ltd. (北海国发川山生物股份有限公司) (600538.SH) reported a net profit of 8.1 million yuan in the first quarter of 2022, up 114.5% year-on-year.

Meanwhile, the company posted 120.8 million yuan in revenue, up 28.5% year-on-year.

At the end of the reporting period, it had 1.1 billion yuan in total assets and 154 million yuan in total liabilities, with a liability-to-asset ratio of 14.2%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST